Verified call record已核验电话会记录 ·
VNDA · Vanda Pharmaceuticals Inc Q3 FY2026 earnings call record财报电话会记录
Verbatim, receipt-bound excerpts from the earnings-call transcript. This is a source record, not a synthesized analysis or recommendation.来自财报电话会文字记录的原文、可追溯摘录。这是来源记录，不是综合分析或推荐。
12 exact excerpts 条原文摘录
27 numeric receipts 个数值回执
B governed source tier 治理来源层级
Transcript present电话会文本已具备
Call language, kept intact.电话会表述，保持原貌。
The excerpts below are selected from the source record under the bounded evidence policy. Wording is not paraphrased; numbers remain the exact spans captured from the call.以下摘录按受限证据策略从来源记录中选出。文字未被改写；数字保持电话会中捕获的精确片段。
“The change in cash during the third quarter of 2026 as compared to the second quarter of 2026 was driven by the net loss in the third quarter of 2026, excluding the impact of non-cash charges such as stock-based compensation and amortization of our intangible and right of use assets, as well as timing of cash received from customers for revenue and related payments of rebates to payers, and the timing of cash paid to third parties for services related to operating expenses and inventory production.”
Kevin Moran · CFO
claim_a75283ed11732efd19678ff1e4ef5721Exact numeric spans精确数值片段
202620262026“The increases as compared to the third quarter of 2025 and the second quarter of 2026 were primarily due to an increase in HETLIOZ revenue as a result of the timing of purchases by specialty pharmacy customers during the year, the timing of shipments to customers at the end of the second quarter of 2026, and growth in Fanapt revenue as a result of the bipolar I commercial launch.”
Kevin Moran · CFO
claim_d005c991da215dadbc99442b666cd9b4Exact numeric spans精确数值片段
202520262026
Member evidence layer会员证据层
10 more verified excerpts continue below.条更多已核验摘录在下方继续。
You have the public source preview. Essential and Pro unlock the complete call record, every remaining numeric receipt, and the full audit table—without replacing source language with generated opinion.你正在阅读公开来源预览。Essential 与 Pro 可解锁完整电话会记录、全部剩余数值回执和完整审计表——不会用生成式观点替代来源原文。
2 public excerpts 条公开摘录10 member excerpts 条会员摘录27 total numeric receipts 个数值回执
Inspect the source receipts检查来源回执39 bound spans个已绑定片段
Each available row identifies the source body, transcript segment and byte span used to verify the visible text.每个可用行都标识用于核验可见文本的来源正文、电话会片段和字节范围。
| Claim主张 | Kind类型 | Segment片段 | Byte span字节范围 | Text hash文本哈希 |
|---|---|---|---|---|
claim_a75283ed11732efd19678ff1e4ef5721 | quote | 17 | 0–503 | 15d08b1d5666bb… |
claim_d4d9030d80a7eb9ad49e31085f9cb343 | numeric | 17 | 47–51 | 158a323a7ba448… |
claim_79eff6f748fdc0611e01eda7b02fe281 | numeric | 17 | 89–93 | 158a323a7ba448… |
claim_137abfddb98b4d5c9088312b2049c3f0 | numeric | 17 | 145–149 | 158a323a7ba448… |
claim_d005c991da215dadbc99442b666cd9b4 | quote | 19 | 0–382 | b1cf307b62fcfb… |
claim_de75b02fcbc5a335fba606fdfe3d88bc | numeric | 19 | 50–54 | b2b2f104d32c63… |
claim_2300462891d5f90fa3fa82ea0ba9a56b | numeric | 19 | 81–85 | 158a323a7ba448… |
claim_3870fed0ff468e2137d20bb5f704a302 | numeric | 19 | 300–304 | 158a323a7ba448… |